Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Alfred J. Spiro"'
Publikováno v:
Pediatric neurology. 72
Objective There is a wide spectrum of clinical manifestations in children with anti– N -methyl-d-aspartate (NMDA) receptor antibody encephalitis from two different health care settings. Methods We describe our experience with 13 patients (median ag
Autor:
Ronald H. Koenig, Alfred J. Spiro
Publikováno v:
Developmental Medicine & Child Neurology. 12:576-581
SUMMARY The authors report the clinical and laboratory assessment of a family in which several members are involved with a neurological disorder characterized by varying degrees of spastic paraparesis associated with sensory deficits. The literature
Publikováno v:
Developmental Medicine & Child Neurology. 9:594-601
SUMMARY A wide variety of clinical manifestations are encountered in the various forms of progressive spinal muscular atrophy of childhood. The family reported here illustrates the relatively slowly progressive form of this disease. The presence of m
Autor:
Alfred J. Spiro
Publikováno v:
AAP Textbook of Adolescent Health Care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9e90d9f881f6e11c45383a353c76da1
https://doi.org/10.1542/9781581105650-part03-ch128
https://doi.org/10.1542/9781581105650-part03-ch128
Publikováno v:
Neurology. 50(2)
The purpose of this study was to compare histologic characteristics of congenital nemaline myopathy (CNM), adult-onset nemaline myopathy (AONM), and human immunodeficiency virus-associated adult-onset nemaline myopathy (HAONM). There was no differenc
Publikováno v:
Archives of neurology. 54(12)
Background: Laminin 2 is a major component of the basal lamina of skeletal muscle cells. It is a heterotrimer composed of 3 chains: merosin (laminin α2 chain), β 1 , and γ 1 . Deficiency of merosin, with or without laminin β 1 chain reduction, is
Autor:
Lester Weiss, Ronald G. Burns, Peggy Blattner, Elena Pegoraro, Eric P. Hoffman, Peter C. Scacheri, Joseph W. Taber, Alfred J. Spiro
It has recently become possible to detect female carriers of Duchenne muscular dystrophy with no affected male relative in the family. These "isolated carriers" represent about 10% of women with high serum creatine phosphokinase (CPK) levels and clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67c9d9fb8162ff2a155044400498b99
http://hdl.handle.net/11577/2533641
http://hdl.handle.net/11577/2533641